Found: 25
Select item for more details and to access through your institution.
N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/696475
- By:
- Publication type:
- Article
MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/125469
- By:
- Publication type:
- Article
Cancer Biology and Prevention in Diabetes.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 6, p. 1380, doi. 10.3390/cells9061380
- By:
- Publication type:
- Article
SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 10, p. 1, doi. 10.1038/s41419-018-1057-0
- By:
- Publication type:
- Article
Hypolipidemic, Hypoglycemic and Anti-oxidant Activities of Flower Extracts of Allamanda Violacea A. DC (Apocynaceae).
- Published in:
- Tropical Journal of Pharmaceutical Research, 2012, v. 11, n. 4, p. 595, doi. 10.4314/tjpr.v11i4.10
- By:
- Publication type:
- Article
Hypolipidemic, Hypoglycemic and Antioxidant Activities of Flower Extracts of Allamanda violacea A.DC. (Apocynaceae).
- Published in:
- Tropical Journal of Pharmaceutical Research, 2012, v. 11, n. 2, p. 225
- By:
- Publication type:
- Article
Identification of 3-((1-(Benzyl(2-hydroxy-2-phenylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrazine-2-carboxylic Acid as a Potential Inhibitor of Non-Nucleosidase Reverse Transcriptase Inhibitors through InSilico Ligand- and Structure-Based Approaches
- Published in:
- Molecules, 2021, v. 26, n. 17, p. 5262, doi. 10.3390/molecules26175262
- By:
- Publication type:
- Article
Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen.
- Published in:
- Diabetes, 2014, v. 63, n. 6, p. 2120, doi. 10.2337/db13-1029
- By:
- Publication type:
- Article
Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 6027, doi. 10.3390/ijms22116027
- By:
- Publication type:
- Article
Editorial: Receptor biology and cell signaling in diabetes: volume II.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1274914
- By:
- Publication type:
- Article
Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1252315
- By:
- Publication type:
- Article
Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs.
- Published in:
- Genes, 2020, v. 11, n. 2, p. 211, doi. 10.3390/genes11020211
- By:
- Publication type:
- Article
microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00904
- By:
- Publication type:
- Article
Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22617-y
- By:
- Publication type:
- Article
Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
- Published in:
- Kidney International, 2015, v. 88, n. 3, p. 479, doi. 10.1038/ki.2015.103
- By:
- Publication type:
- Article
Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis.
- Published in:
- Scientific Reports, 2016, p. 29884, doi. 10.1038/srep29884
- By:
- Publication type:
- Article
Editorial: Combating Diabetes and Diabetic Kidney Disease.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Loss of Mitochondrial Control Impacts Renal Health.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.543973
- By:
- Publication type:
- Article
Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Editorial: Current understanding of complications associated with diabetes.
- Published in:
- Frontiers in Clinical Diabetes & Healthcare, 2023, p. 1, doi. 10.3389/fcdhc.2023.1338656
- By:
- Publication type:
- Article
Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/9172157
- By:
- Publication type:
- Article
Drugs for Diabetes: From Pharmacology to Clinical Application.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 10, p. 1346, doi. 10.3390/ph16101346
- By:
- Publication type:
- Article
Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 8, p. 751, doi. 10.3390/ph14080751
- By:
- Publication type:
- Article